ArticleJournal of molecular histology2026
Codonopsis pilosula extract protects against osteoporosis by reducing oxidative stress and inflammation.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoporosis (OP) is characterized by oxidative stress, inflammasome activation, and disordered bone remodeling. Codonopsis pilosula extract (CPE) possesses antioxidative and immunomodulatory activities, but its role in OP remains unclear. This study evaluated the protective effects of CPE in ovariectomy (OVX)-induced OP and oxidative stress-challenged osteoblasts.An OVX model was established in Sprague-Dawley rats and divided into control, sham, OVX, and CPE groups. CPE was administered by gavage (200 mg/kg/day) for 28 days. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DEXA). Moreover, biomechanical parameters (Fmax, Fmax dL, Emod) were evaluated via three-point bending; and trabecular morphology was assessed through histological staining (H&E for structure, TRAP for osteoclasts, Masson for collagen, and TUNEL for apoptosis). Western blotting quantified osteogenic, pyroptotic, and Wnt/β-catenin proteins. In parallel, MC3T3-E1 osteoblast precursors were subjected to H₂O₂-induced oxidative stress with or without CPE (100 µg/mL; selected from a dose-response, IC₅₀≈107 µg/mL). Cell proliferation (CCK-8, EdU), apoptosis (flow cytometry, TUNEL), ROS accumulation (DCFH-DA), inflammatory cytokines and antioxidant enzyme activity (ELISA), and related signaling proteins were evaluated.OVX rats exhibited reduced BMD and biomechanical strength, trabecular deterioration, increased osteoclasts, apoptosis, and elevated inflammatory cytokines (IL-1β, IL-6). CPE restored BMD, improved bone strength, and reduced levels of key inflammatory cytokines (e.g., IL-1β and IL-6, P < 0.05). CPE suppressed NLRP3, GSDMD-N, cleaved Caspase-1/3, Bax, and necroptotic proteins (p-RIPK1/3, p-MLKL), and restored Bcl-2 and osteoblast markers (Runx2, ALP). Wnt3a, β-catenin, and p-GSK3β which were suppressed in OP rats were normalized by CPE. In vitro, CPE reduced ROS and MDA, restored SOD and GSH-Px, decreased inflammatory protein expression, and enhanced osteoblast proliferation under oxidative stress.In conclusion, CPE mitigates OP progression by reducing oxidative stress and inflammation, thereby protecting bone structure and function. These findings support CPE as a multifunctional natural agent with therapeutic potential for OP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.